title: GPR43: an emerging target for the potential treatment of type 2 diabetes, obesity and insulin resistance.
authors.affiliation: Jubilant Biosys Ltd, Drug Discovery Unit, Metabolic Disorder Lab, 96, 2nd Stage, Industrial Suburb, Yeshwantpur, Bangalore, Karnatka, 560022, India. atul_tiwari@jubilantbiosys.com
authors.forename: Atul
authors.initials: A
authors.lastname: Tiwari